Polynucleotide immunogenic agents

Details Polynucleotide immunogenic agents Polynucleotide immunogenic agents

1997-11-25

2000-10-03

Johnson, Nancy A.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Carbohydrate doai

536 231, 536 235, 4353201, C12N 1563, C12N 1512, A61K 4800

Patent

active

061273449

ABSTRACT:
Polynucleotide immunogenic agents capable of inducing an immune response towards the members of the Epidermal Growth Factor Receptors (EGFR) family are disclosed.

REFERENCES:
patent: 4935341 (1990-06-01), Bargmann
patent: 5401638 (1995-03-01), Carney
patent: 5422262 (1995-06-01), Andersson
patent: 5527703 (1996-06-01), Cully
Plowman, PNAS 87: 4905, 1990.
9.sup.th International Congress of Immunology, San Francisco, Calif., Jul. 23-29, XP000578979, D. Hu et al, "ErbB-2-neu DNA vaccine based immunotherepy", see Abstract 5162, 1995.
Ann. N.Y. Acad. Sci., Nov. 27, 1995, 772 P274-7, U.S., XP000578698, F.M. Venanzi et al, "neu/HER-2 cDNA vaccination and pregnacy loss".
Proc. Natl. Acad. Sci. USA, Oct. 1987, 84 (19) P6854-8, XP002011369, R. Bernards et al., "Effective tumor immunotherapy directed against an oncogene-encoded product using a vaccinia virus vector".
Science, vol. 247, Mar. 1990, DC, pp. 1465-1468, XP000293057, J.A. Wolff et al, "Direct gene transfer into mouse muscle in vivo".
Science, vol. 259, Mar. 1993, DC, pp. 1745-1749, XP002009751, J.B. Ulmer et al, "Heterologous protection against influenza by injection of DNA encoding a viral protein".

Affiliated with

Also associated with

Rating

Polynucleotide immunogenic agents does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Polynucleotide immunogenic agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Polynucleotide immunogenic agents will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-195578